Before joining the department of Health Technology and Services research in 2020, Xavier performed his doctoral research, "Embracing Uncertainty in Health Technology Assessment", at the Maastricht University Medical Centre+. His research interests are the use of simulation models to evaluate the value of new health care technologies and how to improve the transparency of these simulation models. Currently, Xavier is involved in research projects focusing on the early detection of (risk factors for) cardiovascular diseases. Xavier also teaches the basic principles of (early) health economic evaluations in multiple study programs (Bachelor Health Sciences and Master Biomedical Engineering).

Expertise

  • Medicine and Dentistry

    • Cost-Effectiveness Analysis
    • Health Care Cost
    • Patient
    • Quality Adjusted Life Year
    • Therapeutic Procedure
    • Cardiovascular Disease
    • Systematic Review
    • Breast Cancer

Organisations

Publications

2025

Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years (2025)PharmacoEconomics - Open, 9(1), 137–145. Article e000064. Ploumen, E. H., Oude Wolcherink, M. J., Buiten, R. A., Pinxterhuis, T. H., Doggen, C. J. M., Schotborgh, C. E., Danse, P. W., Scholte, M., van Houwelingen, K. G., Zocca, P., Pouwels, X. G. L. V. & von Birgelen, C.https://doi.org/10.1007/s41669-024-00539-x

2024

Cost-effectiveness analysis of transthoracic echocardiographic assessment in patients with ischemic stroke or TIA of undetermined cause (2024)Journal of Stroke & Cerebrovascular Diseases, 33(12). Article 108013. van der Maten, G., Pouwels, X. G. L. V., Meijs, M. F. L., von Birgelen, C., den Hertog, H. M. & Koffijberg, H.https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108013Validating Health Economic Models With the Probabilistic Analysis Check dashBOARD (2024)Value in health, 27(8), 1073-1084. Pouwels, X. G. L. V., Kroeze, K., van der Linden, N., Kip, M. M. A. & Koffijberg, H.https://doi.org/10.1016/j.jval.2024.04.008A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations (2024)PharmacoEconomics, 42(7), 797-810. Wang, J., Pouwels, X., Ramaekers, B., Frederix, G., van Lieshout, C., Hoogenveen, R., Li, X., de Wit, G. A., Joore, M., Koffijberg, H., van Giessen, A., Knies, S. & Feenstra, T.https://doi.org/10.1007/s40273-024-01376-wSource code of the Probabilistic Analysis Check dashBOARD (PACBOARD) (2024)[Dataset Types › Dataset]. Zenodo. Pouwels, X. & Kroeze, K. A.https://doi.org/10.5281/zenodo.11279943Introducing Open Science in Teaching Health Economic Modelling (2024)PharmacoEconomics - Open, 8, 347-357. Pouwels, X. G. L. V. & Koffijberg, H.https://doi.org/10.1007/s41669-023-00469-0Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease (2024)EClinicalMedicine, 68. Article 102414. Pouwels, X. G. L. V., Mil, D. v., Kieneker, L. M., Boersma, C., Etten, R. W. v., Evers-Roeten, B., Heerspink, H. J. L., Hemmelder, M. H., Langelaan, M., Thelen, M., Gansevoort, R. T. & Koffijberg, H.https://doi.org/10.1016/j.eclinm.2023.102414THOMAS_Cost-effectiveness_analysis (2024)[Dataset Types › Dataset]. Areda (University of Twente). Pouwels, X. G. L. V.Cost-effectiveness of screening for chronic kidney disease: existing evidence and knowledge gaps (2024)Clinical Kidney Journal, 17(1). Article sfad254. Mil, D. v., Pouwels, X. G. L. V., Heerspink, H. L. & Gansevoort, R. T.https://doi.org/10.1093/ckj/sfad254

Research profiles

Address

University of Twente

Technohal (building no. 18), room 3306
Hallenweg 5
7522 NH Enschede
Netherlands

Navigate to location

Organisations

Scan the QR code or
Download vCard